Interview 14 Feb 2018
This Biotech Veteran Is Using These Tips for Successful Drug Development, Here Is Why
Our second interview at Refresh in Vienna was with Peter Llewellyn-Davies, the founder of Accellerate Partners and Apeiron's CFO and…
Apeiron Biologics
- Latest Posts
News and Trends 28 Aug 2017
Austrian Biotech Gets €25M of EU Funding to Fight Rare Childhood Cancer
Apeiron Biologics has been granted financing of €25M from the European Investment Bank (EIB) to support the development of new…
News and Trends 8 May 2017
The EU Approves New Treatment for a Rare Pediatric Cancer
Update (08/05/2017): The European Commission has granted marketing authorization to Apeiron Biologic's APN311 in the rare pediatric cancer neuroblastoma. Originally…
News and Trends 12 Sep 2016
Grüßgott, get to Meet 9 exciting Biotechs from Vienna
Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The city has also been at…
ADVERTISEMENT
News and Trends 10 Aug 2015
Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi
Evotec had to announce a setback recently when its Alzheimer's treatment in collaboration with Roche failed in Phase IIb. However,…
